| Product |
Tests-SARS-COV-2
|
|---|---|
| Description of Project |
Cue Health was contracted to ramp-up production of its hand-held diagnostic test for COVID-19. |
| Unique Impact |
The company’s rapid molecular test is based on a nasal swab and a cartridge-based reader and delivers results through a smartphone within about 20 minutes. Cue Health was contracted to provide 30,000 of the reusable, battery-powered instruments by March 2021, while increasing production of its testing kits to 100,000 per day. |
| Base Award Amount |
$480,916,636.62
|
| Category |
Testing Capacity and Raw Materials
|
Official websites use .gov
A .gov website belongs to an official government organization in the United
States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely
connected to the .gov website. Share sensitive information only on official, secure websites.
